Atamestane
Appearance
![]() | |
Clinical data | |
---|---|
Other names | SH-489; Metandroden; 1-Methylandrosta-1,4-diene-3,17-dione |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C20H26O2 |
Molar mass | 298.419 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Atamestane (developmental code name SH-489), also known as metandroden, as well as 1-methylandrosta-1,4-diene-3,17-dione, is a steroidal aromatase inhibitor that was studied in the treatment of cancer.[1] It blocks the production of estrogen in the body. The drug is selective, competitive, and irreversible in its inhibition of aromatase.[2][additional citation(s) needed]
See also
- Boldione (androsta-1,4-diene-3,17-dione)
References
- ^ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 794–. ISBN 978-1-4757-2085-3.
- ^ el Etreby MF (March 1993). "Atamestane: an aromatase inhibitor for the treatment of benign prostatic hyperplasia. A short review". J. Steroid Biochem. Mol. Biol. 44 (4–6): 565–72. doi:10.1016/0960-0760(93)90260-4. PMID 7682838.
External links
- Atamestane entry in the public domain NCI Dictionary of Cancer Terms
This article incorporates public domain material from Dictionary of Cancer Terms. U.S. National Cancer Institute.